Gatifloxacin Carboxyclic Acid Ethyl Ester CAS 112811-71-9 Dị Ọcha> 99.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd bụ onye na-emepụta Gatifloxacin Carboxyclic Acid Ethyl Ester (CAS: 112811-71-9) nwere oke mma.Ruifu Chemical nwere ike ịnye nnyefe zuru ụwa ọnụ, ọnụahịa asọmpi, ọrụ magburu onwe ya, obere na nnukwu ọnụọgụ dị.Ịzụta Gatifloxacin na Moxifloxacin Hydrochloride etiti,Please contact: alvin@ruifuchem.com
Aha Chemical | Gatifloxacin Carboxyclic Acid Ethyl Ester |
Ụdị okwu | Ethyl 1-Cyclopropyl-6,7-Difluoro-1,4-Dihydro-8-Methoxy-4-Oxo-3-Quinolinecarboxylate;Ethyl 1-Cyclopropyl-6,7-Difluoro-8-Methoxy-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate;1-Cyclopropyl-6,7-Difluoro-1,4-Dihydro-8-Methoxy-4-Oxo-3-Quinolinecarboxylic Acid Ethyl Ester;1-Cyclopropyl-6,7-Difluoro-8-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-3-Carboxylic Acid Ethyl Ester;Gatifloxacin Carboxyclic Acid Ethyl Ester;Moxifloxacin Difluoro Methoxy Ethyl Ester |
Ọnọdụ Ahịa | Na ngwaahịa, Mmepụta Azụmahịa |
Nọmba CAS | 112811-71-9 |
Usoro ihe omimi | C16H15F2NO4 |
Ibu molekụla | 323.30 g / mol |
Ebe Na-agbaze | 182.0 ruo 186.0 ℃ |
Njupụta | 1.414±0.06 g/cm3 |
Mmetụta | Okpomọkụ nwere mmetụta |
COA & MSDS | Dị |
Mmalite | Shanghai, China |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta | Nsonaazụ | Ụzọ ule |
Ọdịdị | Gbanyụọ-White Crystalline ntụ ntụ | Na-akwado | Site nleba anya nke anụ ahụ |
Ụzọ ịdị ọcha / nyocha | > 99.0% (HPLC) | 99.80% | HPLC |
Ebe Na-agbaze | 182.0 ~ 186.0 ℃ | 182.5-185.5 ℃ | Ụdị nke abụọ CP2005 Akụkụ Addendum VI C |
Ọnwụ na ihicha | <0.50% | 0.08% | Ụdị nke abụọ CP2005 Akụkụ Addendum VIII L |
Ihe fọdụrụ na mgbanye | <0.20% | 0.08% | Ụdị nke abụọ CP2005 Akụkụ Addendum VIII N |
Otu adịghị ọcha | <0.50% | 0.06% | HPLC |
Mgbakọta adịghị ọcha | <1.00% | 0.20% | HPLC |
1H NMR Spectrum | Nkwekọ na Structure | Na-akwado | |
Mmechi | A nwalela ngwaahịa a wee kwado nkọwa ndị enyere | ||
Ngwa | Ọkara nke Gatifloxacin / Moxifloxacin Hydrochloride |
ngwugwu:Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Debe akpa ahụ nke ọma ma chekwaa n'ebe dị jụụ, kpọrọ nkụ (2 ~ 8 ℃) yana ụlọ nkwakọba ihe nke ọma na-esi na ihe ndị na-adabaghị adaba.Chebe ọkụ na mmiri, zere ọkụ na okpomọkụ.
Mbupu:Jiri ikuku na-ebuga ụwa niile site na FedEx / DHL Express.Nye nnyefe ngwa ngwa na ntụkwasị obi.
Kedu ka esi azụta?Biko kpọtụrụDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Ahụmịhe afọ 15?Anyị nwere ihe karịrị 15 afọ nke ahụmahụ na mmepụta na mbupụ nke a dịgasị iche iche nke elu mma pharmaceutical intermediates ma ọ bụ ezi kemịkal.
Isi ahịa?Na-ere ahịa ụlọ, North America, Europe, India, Korea, Japanese, Australia, wdg.
Uru?Ogo kachasị elu, ọnụ ahịa dị ọnụ ala, ọrụ ọkachamara na nkwado teknụzụ, nnyefe ngwa ngwa.
OgoNkwenye?Usoro njikwa mma siri ike.Ngwá ọrụ ọkachamara maka nyocha gụnyere NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, wdg.
Ihe atụ?Ọtụtụ ngwaahịa na-enye ihe nlele efu maka nyocha dị mma, ndị ahịa kwesịrị ịkwụ ụgwọ mbupu.
Nyocha ụlọ ọrụ?Nnabata nyocha ụlọ ọrụ.Biko mee oge oge tupu oge eruo.
MOQ?Enweghị MOQ.A na-anabata obere usoro.
Oge Mbuga ozi? Ọ bụrụ n'ime ngwaahịa, ekwenyere nnyefe ụbọchị atọ.
Ụgbọ njem?Site Express (FedEx, DHL), nke ikuku, site n'oké osimiri.
Akwụkwọ?Mgbe ọrụ ahịa gasịrị: COA, MOA, ROS, MSDS, wdg nwere ike ịnye.
Synthesis omenala?Nwere ike ịnye ọrụ nhazi ahaziri iche ka ọ dabara mkpa nyocha gị nke ọma.
Usoro ịkwụ ụgwọ?A ga-ebu ụzọ ziga akwụkwọ ọnụahịa Proforma mgbe nkwenye nke iwu, kpuchiri ozi ụlọ akụ anyị.Ịkwụ ụgwọ site na T/T (Telex Nyefee), PayPal, Western Union, wdg.
Ethyl 1-Cyclopropyl-6,7-Difluoro-1,4-Dihydro-8-Methoxy-4-Oxo-3-Quinolinecarboxylate (Gatifloxacin Carboxyclic Acid Ethyl Ester) (CAS: 112811-71-9) bụ etiti nke Gatifloxacin. CAS: 112811-59-3) / Moxifloxacin Hydrochloride (CAS: 186826-86-8).
Gatifloxacin bụ ọgbọ nke anọ fluoroquinolone nke ndị otu agbụrụ nke 8-methofluoroquinolones, nwere ụdị dị iche iche nke mgbochi gram-adịghị mma na microorganisms dị mma, nke Japanese Xinglin Pharmaceutical Co., Ltd. mepụtara maka oge mbụ nke ọma. ndị R-na S-enantiomers nke otu antibacterial ọrụ, site na igbochi nje bacteria DNA gyrase na topoisomerase IV, nke na-egbochi nje DNA replication, transcription na nhazi usoro iji rụọ ọrụ, nwere mmetụta antibacterial siri ike na nje bacteria dị iche iche, ọ nwere a mmetụta dị mma na ọrịa iku ume na ọrịa usoro ọmụmụ, ọ bụkwa otu n'ime ndị nnọchianya nke ọgwụ "Respiratory fluoroquinolones" nke toro ngwa ngwa n'afọ ndị na-adịbeghị anya.Clinical tumadi maka ọgwụgwọ nke ọrịa dị iche iche nke dị nwayọọ na-agafeghị oke na-efe efe kpatara site na mmetụta nke pathogens, gụnyere: nnukwu exacerbation nke na-adịghị ala ala bronchitis, nnukwu sinusitis, Community enwetara ka oyi baa, mfe urinary tract ọrịa (cystitis) na mgbagwoju urinary tract ọrịa, cystitis, nnukwu. Pyelonephritis na ọrịa nke urethra, cervix, ikensi nke Neisseria gonorrhoeae kpatara.
Moxifloxacin Hydrochloride bụ ọgwụ nje fluoroquinolone nke Bayer Pharmaceuticals na Germany mepụtara.Usoro ọrụ ya na in vitro antibacterial spectrum yiri ọgwụ ndị ọzọ fluoroquinolone, ma antibacterial ọrụ megide gram-positive bacteria na anaerobic nje bacteria yiri nke travaxacin (trovafloxacin), nke dị mma karịa ụfọdụ ochie ụdị.E jiri ya tụnyere fluoroquinolones ndị ọzọ, nje bacteria gram-positive na-eguzogide ngwaahịa a dị ole na ole ma ọ bụ dị ngwa ngwa.Achọpụtala nje bacteria na-eguzogide ọgwụ na fluoroquinolones ndị ọzọ na nje bacteria gram-negative na Enterococcus.Agbanyeghị, ngwaahịa a dị opekata mpe dị irè maka staphylococcus aureus iche grlA,grlB,gyrA ma ọ bụ gyrB.Ngwaahịa a nwere ike igbochi staphylococcus aureus na-eguzogide ciprofloxacin na 0.5 ~ 2 mg / L, yana ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin na moxifloxacin na-agbada n'usoro dịka MIC siri kwuo.